| HOME >> MEDICINE >> TECHNOLOGY |
Figure 9: GPCRs in Drug Discovery, Pipeline Analysis for Molecules Targeting GPCRs by Phase, 2011 45
Figure 10: GPCRs in Drug Discovery, Central Nervous System, Number of Molecules Targeting GPCRs By Phase, 2011 46
Figure 11: GPCRs in Drug Discovery, Central Nervous System, Top 10 Indications By Total Molecules In Pipeline, 2011 47
Figure 12: GPCRs in Drug Discovery, Oncology, Number of Molecules Targeting GPCRs By Phase, 2011 52
Figure 13: GPCRs in Drug Discovery, Oncology, Top 10 Indications By Total Molecules In Pipeline, 2011 53
Figure 14: GPCRs in Drug Discovery, Cardiovascular System, Number of Molecules Targeting GPCRs By Phase, 2011 56
Figure 15: GPCRs in Drug Discovery, Cardiovascular System, Top 10 Indications By Total Molecules In Pipeline, 2011 57
Figure 16: GPCRs in Drug Discovery, Metabolic Disorders, Number of Molecules Targeting GPCRs By Phase, 2011 60
Figure 17: GPCRs in Drug Discovery, Metabolic Disorders, Top 10 Indications By Total Molecules In Pipeline, 2011 61
Figure 18: GPCRs in Drug Discovery, Gastrointestinal Disorders, Number of Molecules Targeting GPCRs By Phase, 2011 64
Figure 19: GPCRs in Drug Discovery, Gastrointestinal Disorders, Top 10 Indications By Total Molecules In Pipeline, 2011 65
Figure 20: GPCRs in Drug Discovery, Respiratory Diseases, Number of Molecules Targeting GPCRs By Phase, 2011 67
Figure 21: GPCRs in Drug Discovery, Respiratory Diseases, Top 10 Indications By Total Molecules In Pipeline, 2011 68
Figure 22: GPCRs in Drug Discovery, Immunology, Number of Molecules Targeting GPCRs By Phase, 2011 71
Figure 23: GPCRs in Drug Discovery, Immunology, Top 10 Indications By Total Molecules In Pipeline, 2011 72
Figure 24: GPCRs in Drug Discovery, Women's Health, Number of Molecules Targeting GPCRs By Phase, 2011 74
'/>"/>| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |